Stable gastric pentadecapeptide BPC 157 is an anti-ulcer peptidergic agent, safe in inflammatory bowel disease clinical trials (GEPPPGKPADDAGLV, M.W. 1419, PL 14736) and wound healing, stable in human gastric juice and has no reported toxicity.
CAT No: HB00106
CAS No:137525-51-0
Synonyms/Alias:Bpc-157;Bpc 157;137525-51-0;Bepecin;Bpc 15;Bpc157;Booly protection compound 15;pl-10;UNII-8ED8NXK95P;PLD-116;L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-;PL-14736;Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val;MFCD06407962;Bpc15;BPC-157 free base;8ED8NXK95P;BPC-15;CHEMBL4297358;EX-A4283;AKOS032945961;DB11882;BS-14984;D84081;Q27270252;(2S,5S,11S,14S,17S)-14-(Carboxymethyl)-17-((S)-2-((S)-1-(glycyl-L-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl)pyrrolidine-2-carboxamido)propanamido)-5-isobutyl-2-isopropyl-11-methyl-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazanonadecanedioic acid;
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.